Cerity Partners
BCYC

Cerity Partners’s Bicycle Therapeutics BCYC Stock Holding History

Cerity Partners’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63K Buy
13,570
+220
+2% +$1.26K ﹤0.01% 3079
2025
Q4 		$94.5K Sell
13,350
-1,000
-7% -$7.37K ﹤0.01% 2756
2025
Q3 		$111K Hold
14,350
– – ﹤0.01% 2617
2025
Q2 		$99.7K Buy
14,350
+1,000
+7% +$7.96K ﹤0.01% 2479
2025
Q1 		$113K Buy
+13,350
New +$157K ﹤0.01% 2308

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cerity Partners's BCYC Position: Q1 2026 in Review

Cerity Partners increased its Bicycle Therapeutics (BCYC) stake by 1.6% in Q1 2026, buying an estimated $1.26K and bringing the position to 13,570 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #3079.

Cerity Partners first reported a position in BCYC in Q1 2025 and has held it in 5 quarters since. The position peaked at $113K in Q1 2025. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Cerity Partners held 13,570 shares of Bicycle Therapeutics worth $63K as of Q1 2026.
  • Cerity Partners bought 220 Bicycle Therapeutics shares in Q1 2026, an estimated $1.26K.
  • Bicycle Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #3079 holding.
  • Cerity Partners first reported a position in Bicycle Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Cerity Partners's Bicycle Therapeutics position peaked at $113K in Q1 2025.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.